Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with standard ...

A single blood test could help doctors predict how lung cancer patients will respond to treatment before therapy begins, ...

For nearly half of people diagnosed with lung cancer, immunotherapy can slow the disease but not stop it. Funded through a $4 million joint investment from the Canadian Cancer Society (CCS) and the ...

Roche brings subcutaneous Atezolizumab to India, shot costs Rs 3.7 lakh per dose with most patients needing around six doses ...

Treatment with the TROP2 ADC sac-TMT led to a 70% objective response rate and progression-free survival was “significantly ...

India launches a seven-minute lung cancer immunotherapy injection Tecentriq that may improve patient comfort and reduce ...

Cancer survival might depend on what time of day you get your treatment, a new study says. Lung cancer patients who received IV immunotherapy doses earlier in the day tended to live longer, ...

Scientists, medical researchers at Case Western Reserve, NYU Langone Health and University Hospitals using machine-learning to predict response to immunotherapy Medical researchers from Case Western ...

As life expectancy increases, 1 in 2 men and 1 in 3 women will be diagnosed with cancer at least once in their lifetime and ...

Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the ...

GENEVA — Lung cancer researchers continue to be excited over the potential for immunotherapy, and the subject was given a top billing here in a keynote lecture on the first day of the European Lung ...

We get one body, one mind, one soul and what are we going to do with it?" Lipchock, who lives in Washington Township with her ...